REFUND Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Aug 9, 2019)
Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties.
The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)
What just happenedAug 12, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseAug 9, 2019
- Aug 12, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Aug 9, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Aug 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Aug 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Aug 9, 2019IntroReferralIntro-H
Introduced in House
- Aug 9, 2019IntroReferral1000
Introduced in House